Cargando…
Pharmaconutrition in the Clinical Management of COVID-19: A Lack of Evidence-Based Research But Clues to Personalized Prescription
A scientific interest has emerged to identify pharmaceutical and nutritional strategies in the clinical management of coronavirus disease 2019 (COVID-19). The purpose of this narrative review is to critically assess and discuss pharmaconutrition strategies that, secondary to accepted treatment metho...
Autores principales: | Santos, Heitor O., Tinsley, Grant M., da Silva, Guilherme A. R., Bueno, Allain A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712662/ https://www.ncbi.nlm.nih.gov/pubmed/32992693 http://dx.doi.org/10.3390/jpm10040145 |
Ejemplares similares
-
Current knowledges in pharmaconutrition: “Ketogenics” in pediatric gliomas
por: Cecchi, Nicola, et al.
Publicado: (2023) -
Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
por: Kones, Richard
Publicado: (2010) -
Long-chain omega-3 fatty acids in aneurysmal subarachnoid hemorrhage: A randomized pilot trial of pharmaconutrition
por: Saito, Geisi, et al.
Publicado: (2017) -
Pharmaconutrition revisited for critically ill patients with coronavirus disease 2019 (COVID-19): Does selenium have a place?
por: Manzanares, William, et al.
Publicado: (2021) -
The effectiveness of automated digital health solutions at
successfully managing obesity and obesity-associated disorders: A
PICO-structured investigation
por: Price, James Christopher, et al.
Publicado: (2022)